Nigeria - 2018 - Health

NAFDAC Regulatory and Registration of Biosimilars in Nigeria

Ministry of Health, National Agency for Food and Drug Administration and Control, Nigeria

These guidelines are for the interest of the general public and in particular, pharmaceutical industries in Nigeria. The document provides guidelines for the registration of biosimilars in Nigeria.

Process Flow

Department of Registration and Regulatory Affairs ⬤

Office of the Director General NAFDAC ⬤

Office of the Permanent Secretary, Ministry of Health ⬤

Office of the Minister of State for Health ⬤

Office of the minister for health ⬤

Federal Executive Council ⬤

Compare Versions Please select two versions

NAFDAC Regulatory and Registration of Biosimilars in Nigeria Current Version

January 2022

These guidelines are for the interest of the general public and in particular, pharmaceutical industries in Nigeria. The document provides guidelines for the registration of biosimilars in Nigeria.

Request Expert Analysis

Ask one of our policy analysts to take an in-depth look at this policy and provide you with a written summary. An additional cost may apply. Please let us know what questions you are looking to answer.

Thank you for requesting an expert analysis

A member of our team will review your request and reply back to the email address on file.